Bioretec’s target is to receive the CE mark and to introduce the bioresorbable magnesium alloy trauma screw into the markets in the European Union during 2022.
Designed to enhance ease-of-use and to provide greater precision and control throughout the procedure, Lumeseal is announced as the successor of the efficient and widely used ENDOTHERME 1470 platform.
"The integration of SnakeBack® technology on LUMESEAL® is a big step forward for the development of the technique. Beyond its direct impact on enhancing the reproducibility and comfort of laser delivery, the LUMESEAL® platform allows us to assess further improvements in the EVLT technique (new wavelengths, applicators,) "says M. Rochon, LSO Medical CEO.
The PUMA System™ is a new category of minimally invasive devices, enabling ultrasound to be used for procedures in hollow organs of the body where previously it was impossible or unsafe to do so.
EG-UC5T is characterized by its large, 4.0-mm instrument channel and its short rigid distal end, pushing the boundaries of therapeutic excellence.
The CE mark approval of the UNITY-B Percutaneous Biodegradable implant represents yet another milestone for QualiMed and all the companies of Q3 Medical and our collective mission of Creating Value By Helping People.